ACA
CME icon

Aptus Capital Advisors’s CME Group CME Stock Holding History

Aptus Capital Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
7,264
-398
-5% -$110K 0.01% 537
2026
Q1 		$2.26M Sell
7,662
-352
-4% -$105K 0.02% 459
2025
Q4 		$2.19M Sell
8,014
-340
-4% -$92.4K 0.02% 431
2025
Q3 		$2.26M Buy
8,354
+1,313
+19% +$357K 0.02% 411
2025
Q2 		$1.94M Buy
7,041
+1,466
+26% +$399K 0.02% 430
2025
Q1 		$1.48M Buy
5,575
+358
+7% +$88.3K 0.02% 443
2024
Q4 		$1.22M Buy
5,217
+2,210
+73% +$508K 0.01% 468
2024
Q3 		$663K Buy
3,007
+121
+4% +$25K 0.01% 483
2024
Q2 		$567K Buy
2,886
+147
+5% +$30.4K 0.01% 480
2024
Q1 		$590K Buy
2,739
+425
+18% +$89.3K 0.01% 478
2023
Q4 		$487K Buy
2,314
+25
+1% +$5.33K 0.01% 381
2023
Q3 		$458K Buy
2,289
+911
+66% +$181K 0.01% 398
2023
Q2 		$255K Buy
1,378
+135
+11% +$24.9K 0.01% 440
2023
Q1 		$238K Buy
+1,243
New +$225K 0.01% 439
2022
Q4 		– Sell
-22,885
Closed -$4.05M – 807
2022
Q3 		$4.05M Buy
+22,885
New +$4.52M 0.1% 123

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Aptus Capital Advisors's CME Position: Q2 2026 in Review

Aptus Capital Advisors reduced its CME Group (CME) stake by 5.2% in Q2 2026, selling an estimated $110K and leaving 7,264 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #537.

Aptus Capital Advisors first reported a position in CME in Q3 2022 and has held it in 15 quarters since. The position peaked at $4.05M in Q3 2022. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Aptus Capital Advisors held 7,264 shares of CME Group worth $1.6M as of Q2 2026.
  • Aptus Capital Advisors sold 398 CME Group shares in Q2 2026, an estimated $110K.
  • CME Group made up 0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #537 holding.
  • Aptus Capital Advisors first reported a position in CME Group in Q3 2022 and has held it in 15 quarters since.
  • Aptus Capital Advisors's CME Group position peaked at $4.05M in Q3 2022.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.